Efficacy of Carbamazepine and Its Derivatives in the Treatment of Bipolar Disorder
Grunze, Anna (Psychiatrisches Zentrum Nordbaden)
Amann, Benedikt L. (Universitat Autònoma de Barcelona. Departament de Psiquiatria i de Medicina Legal)
Grunze, Heinz (Paracelsus Medical University)

Data:	2021
Resum:	Background and Objectives: This review is dedicated to the use of carbamazepine and its derivatives oxcarbazepine and eslicarbazepine in bipolar disorder and their relative strengths in treating and preventing new depressive or manic episodes. This paper will discuss the evidence of their efficacy relative to the polarity of relapse from controlled acute and maintenance/relapse prevention studies in bipolar patients. Materials and Methods: A Medline search was conducted for controlled acute and maintenance studies with carbamazepine, oxcarbazepine, and eslicarbazepine in bipolar disorder. In addition, abstracts reporting on controlled studies with these medications from key conferences were taken into consideration. Results: Information was extracted from 84 articles on the acute and prophylactic efficacy of the medications under consideration. They all appear to have stronger efficacy in treating acute mania than depression, which also translates to better protection against manic than depressive relapses for carbamazepine. Still, there is a paucity of controlled acute studies on bipolar depression for all and, with the exception of carbamazepine, a lack of long-term monotherapy maintenance data. For eslicarbazepine, the efficacy in bipolar disorder remains largely unknown. Especially with carbamazepine, tolerability issues and drug-drug interactions need to be kept in mind. Conclusions: Two of the medications discussed in this review, carbamazepine and oxcarbazepine, match Class A criteria according to the criteria proposed by Ketter and Calabrese, meaning acute antimanic efficacy, prevention of manic relapses, and not causing or worsening depression.
Ajuts:	Ministerio de Economía y Competitividad PI/15/02242 Instituto de Salud Carlos III PI18/00009
Drets:	Aquest document està subjecte a una llicència d'ús Creative Commons. Es permet la reproducció total o parcial, la distribució, la comunicació pública de l'obra i la creació d'obres derivades, fins i tot amb finalitats comercials, sempre i quan es reconegui l'autoria de l'obra original.
Llengua:	Anglès
Document:	Article ; recerca ; Versió publicada
Matèria:	Bipolar disorder ; Carbamazepine ; Depression ; Eslicarbazepine ; Maintenance ; Mania ; Oxcarbazepine ; Predominant polarity
Publicat a:	Medicina, Vol. 57 (april 2021) , ISSN 1648-9144

DOI: 10.3390/medicina57050433
PMID: 33946323

17 p, 380.3 KB

El registre apareix a les col·leccions:
Articles > Articles de recerca
Articles > Articles publicats